Overview

SCIENTIFIC SCORE
Possibly Effective
Based on 16 Researches
7.5
USERS' SCORE
Moderately Good
Based on 5 Reviews
7.6
Supplement Facts
Serving Size:  1 Capsule
Amount Per Serving
%DV
Magnesium(from 513 mg Buffered Magnesium Glycinate Chelate Complex [Magnesium Oxide and Magnesium Bisglycinate])
200 mg
48%
Magnesium-Rich Plants BlendOrganic Spinach LeafOrganic Chard LeafOrganic Okra FruitOrganic Quinoa Grain (Chenopodium quinoa)Organic Black Bean (Phaseolus vulgaris)Organic Pumpkin SeedOrganic Sunflower SeedOrganic Flaxseed
30 mg
**

Top Medical Research Studies

We investigated the clinical safety and performance of a new magnesium scaffold known as DREAMS 3G. This innovative treatment aims to match the effectiveness of drug-eluting stents in coronary interventions.

Over one year, a total of 116 patients were monitored, showing promising results with minimal lumen loss and no adverse events like cardiac death or major thrombosis. Despite a few revascularization interventions, the scaffold appears to be a viable alternative.

Overall, our findings support its potential use in heart treatments.
Read More
9
Magnesium nanoparticles enhance clotting time
We investigated the effects of magnesium oxide nanoparticles, created using fruit extract, on blood clotting and oxidative stress. Our experiments showed that these nanoparticles significantly extended clotting time, indicating an anticoagulant effect. They also effectively reduced damage to red blood cells and various tissues in laboratory tests, helping to restore their function. Importantly, we found these nanoparticles non-toxic, suggesting they could be a promising treatment option for oxidative stress-related conditions without adverse side effects. However, further research is needed to fully understand their potential in clinical applications.
Read More
8
Magnesium scaffolds lower clotting risks
We aimed to examine how bioresorbable magnesium scaffolds influence blood clotting. Using a cutting-edge stent flow chamber system, we compared the thrombogenicity of various stents, including the Magmaris magnesium scaffold and a prototype called DREAMS 3G.

Our findings indicated that the Magmaris scaffold exhibited significantly lower thrombogenicity than traditional stainless steel stents. Impressively, the DREAMS 3G prototype demonstrated even further reductions in clotting risks, suggesting it could enhance patient safety.

This study highlights the potential of magnesium-based scaffolds in improving cardiovascular treatments.
Read More

Most Useful Reviews

7
Lowers blood pressure
1 people found this helpful
I noticed a positive effect on my blood pressure after discovering the link between magnesium deficiency and hypertension. Initially on the verge of high blood pressure, it has stabilised around 130, which is quite nice!
Read More
2
Not effective treatment
2 people found this helpful
Magnesium Glycinate is somewhat challenging to acquire, but it's been essential for me for over two years. My previous brand helped manage my blood pressure effectively, even at a low dose. Unfortunately, this brand did not have the same impact on my blood clot condition. The price is reasonable, and 200mg is a suitable starting dose for those with magnesium deficiency, though one must be cautious not to exceed the recommended amount. I am not entirely disheartened by this brand as there may be various reasons for its ineffectiveness for me. While this supplement didn't meet my needs, it could potentially benefit others. A significant advantage is that it is vegetarian-friendly.
Read More
6
Eases discomfort effectively
1 people found this helpful
Magnesium glycinate chelate is easily absorbed without causing an upset stomach. It supports healthy physical functioning, relieving stress and discomfort, as well as aiding the heart and blood vessels to maintain circulation and blood pressure. Its natural ingredients contribute to overall well-being.
Read More

Medical Researches

SCIENTIFIC SCORE
Possibly Effective
Based on 16 Researches
7.5
  • All Researches
9
Magnesium nanoparticles enhance clotting time
We investigated the effects of magnesium oxide nanoparticles, created using fruit extract, on blood clotting and oxidative stress. Our experiments showed that these nanoparticles significantly extended clotting time, indicating an anticoagulant effect. They also effectively reduced damage to red blood cells and various tissues in laboratory tests, helping to restore their function. Importantly, we found these nanoparticles non-toxic, suggesting they could be a promising treatment option for oxidative stress-related conditions without adverse side effects. However, further research is needed to fully understand their potential in clinical applications.
Read More
8
Magnesium intake reduces RVO risk
We explored whether magnesium intake could influence the risk of retinal vein occlusion (RVO), a leading cause of vision loss. Our analysis involved over 16,000 participants from a national health survey.

We discovered that sufficient magnesium intake was linked to a significant 64% reduced risk of RVO.

This finding was especially relevant for adults under 60, those with hypertension, and individuals without glaucoma. Further studies are needed to confirm magnesium's preventive benefits for RVO.
Read More
8
Effective clay-based hemostatic sponge
We examined a new sponge made from clay and collagen to control severe bleeding. Integrating palygorskite clay with collagen using gallic acid created a sponge that resists particle shedding and provides strong adhesion.

In our tests, this sponge demonstrated impressive results, reducing blood loss to 632 mg and achieving hemostasis in just 151 seconds, outperforming traditional gauze and even a well-known product called QuikClot.

With added antibacterial and antioxidant properties, this sponge could significantly enhance emergency bleeding management.
Read More
8
Magnesium scaffolds lower clotting risks
We aimed to examine how bioresorbable magnesium scaffolds influence blood clotting. Using a cutting-edge stent flow chamber system, we compared the thrombogenicity of various stents, including the Magmaris magnesium scaffold and a prototype called DREAMS 3G.

Our findings indicated that the Magmaris scaffold exhibited significantly lower thrombogenicity than traditional stainless steel stents. Impressively, the DREAMS 3G prototype demonstrated even further reductions in clotting risks, suggesting it could enhance patient safety.

This study highlights the potential of magnesium-based scaffolds in improving cardiovascular treatments.
Read More
8
Bioresorbable stents' advancements noted
We explored the evolution of bioresorbable metallic stents as alternatives to traditional stents which can lead to complications like thrombosis and inflammation.

While bioresorbable polymeric stents face challenges, materials like zinc and magnesium show promise.

Specifically, magnesium-based stents have demonstrated successful absorption within a year and low rates of complications.

Continuing research will be essential to refine these innovations for better clinical outcomes.
Read More

User Reviews

USERS' SCORE
Moderately Good
Based on 5 Reviews
7.6
  • All Reviews
  • Positive Reviews
  • Negative Reviews
7
Lowers blood pressure
1 people found this helpful
I noticed a positive effect on my blood pressure after discovering the link between magnesium deficiency and hypertension. Initially on the verge of high blood pressure, it has stabilised around 130, which is quite nice!
Read More
2
Not effective treatment
2 people found this helpful
Magnesium Glycinate is somewhat challenging to acquire, but it's been essential for me for over two years. My previous brand helped manage my blood pressure effectively, even at a low dose. Unfortunately, this brand did not have the same impact on my blood clot condition. The price is reasonable, and 200mg is a suitable starting dose for those with magnesium deficiency, though one must be cautious not to exceed the recommended amount. I am not entirely disheartened by this brand as there may be various reasons for its ineffectiveness for me. While this supplement didn't meet my needs, it could potentially benefit others. A significant advantage is that it is vegetarian-friendly.
Read More
6
Eases discomfort effectively
1 people found this helpful
Magnesium glycinate chelate is easily absorbed without causing an upset stomach. It supports healthy physical functioning, relieving stress and discomfort, as well as aiding the heart and blood vessels to maintain circulation and blood pressure. Its natural ingredients contribute to overall well-being.
Read More
7.5
Good for aging bones
It's beneficial for my bones, especially in later life, and for managing high blood pressure as well.
Read More
7.5
Calms before sleep
Great value and quality! I feel calm after taking this before sleep. It also lowers blood pressure and relaxes the body—an excellent ingredient.
Read More

Frequently Asked Questions

7
Lowers blood pressure
1 people found this helpful
I noticed a positive effect on my blood pressure after discovering the link between magnesium deficiency and hypertension. Initially on the verge of high blood pressure, it has stabilised around 130, which is quite nice!
2
Not effective treatment
2 people found this helpful
Magnesium Glycinate is somewhat challenging to acquire, but it's been essential for me for over two years. My previous brand helped manage my blood pressure effectively, even at a low dose. Unfortunately, this brand did not have the same impact on my blood clot condition. The price is reasonable, and 200mg is a suitable starting dose for those with magnesium deficiency, though one must be cautious not to exceed the recommended amount. I am not entirely disheartened by this brand as there may be various reasons for its ineffectiveness for me. While this supplement didn't meet my needs, it could potentially benefit others. A significant advantage is that it is vegetarian-friendly.
6
Eases discomfort effectively
1 people found this helpful
Magnesium glycinate chelate is easily absorbed without causing an upset stomach. It supports healthy physical functioning, relieving stress and discomfort, as well as aiding the heart and blood vessels to maintain circulation and blood pressure. Its natural ingredients contribute to overall well-being.
7.5
Calms before sleep
Great value and quality! I feel calm after taking this before sleep. It also lowers blood pressure and relaxes the body—an excellent ingredient.
7.5
Good for aging bones
It's beneficial for my bones, especially in later life, and for managing high blood pressure as well.
We studied how a lack of magnesium transporter 1 (MAGT1) impacts blood clot formation and the risk of stroke. Using various laboratory and animal models, we observed that MAGT1 deficiency leads to enhanced platelet activity and quicker clotting. This deficiency resulted in faster artery blockage and severe brain damage during strokes. Interestingly, restoring magnesium levels or blocking certain channels helped normalize platelet behavior. Overall, we found that MAGT1's function is crucial for vascular health, indicating its deficiency could elevate risks for thrombosis and ischemic stroke.
8
Magnesium scaffolds lower clotting risks
We aimed to examine how bioresorbable magnesium scaffolds influence blood clotting. Using a cutting-edge stent flow chamber system, we compared the thrombogenicity of various stents, including the Magmaris magnesium scaffold and a prototype called DREAMS 3G.

Our findings indicated that the Magmaris scaffold exhibited significantly lower thrombogenicity than traditional stainless steel stents. Impressively, the DREAMS 3G prototype demonstrated even further reductions in clotting risks, suggesting it could enhance patient safety.

This study highlights the potential of magnesium-based scaffolds in improving cardiovascular treatments.
7
Magnesium scaffold safe and effective
We examined the effectiveness of the Magmaris magnesium scaffold on patients with stable coronary artery disease (SCAD) and acute coronary syndrome (ACS) over two years. By looking at data from the Magmaris Multicenter Italian Registry, we found that the rates of target lesion failure and scaffold thrombosis remained low for both groups. Specifically, TLF was 7.4% for SCAD and 8.8% for ACS patients, with scaffold thrombosis observed at 0% and 1.8%, respectively. Overall, the findings suggest that this magnesium scaffold is safe and effective.
9
Magnesium nanoparticles enhance clotting time
We investigated the effects of magnesium oxide nanoparticles, created using fruit extract, on blood clotting and oxidative stress. Our experiments showed that these nanoparticles significantly extended clotting time, indicating an anticoagulant effect. They also effectively reduced damage to red blood cells and various tissues in laboratory tests, helping to restore their function. Importantly, we found these nanoparticles non-toxic, suggesting they could be a promising treatment option for oxidative stress-related conditions without adverse side effects. However, further research is needed to fully understand their potential in clinical applications.

References

  1. Kim J, Kim M, Lee CS, Choi EY. Sufficient Magnesium Intake Reduces Retinal Vein Occlusion Risk: National Health and Nutrition Examination Survey Analysis. Nutrients. 2025;17. doi:10.3390/nu17071285
  2. Guo X, Zeng X, He Y, Zhang X, Shi W, et al. An Antibacterial, Antioxidant Adherent Sponge Constructed for Control of Arterial Bleeding Via Gallic Acid-Mediated Robust Assembly of Fibrous Clay in Collagen. ACS Appl Mater Interfaces. 2025;17:16489. doi:10.1021/acsami.4c19209
  3. Müller M, Ludwig L, Englert H, Riedl KA, Müller MC, et al. A novel stent flow chamber system demonstrates reduced thrombogenicity of bioresorbable magnesium scaffolds. Sci Rep. 2024;14:26691. doi:10.1038/s41598-024-77266-0
  4. Zhang J, Chen Z, Rao L, He Y. Coronary bioresorbable metallic stents: Advancements and future perspectives. J Cardiol. 2025;85:69. doi:10.1016/j.jjcc.2024.08.003
  5. Włodarczak A, Rola P, Włodarczak S, Szudrowicz M, Giniewicz K, et al. Two-Year Outcomes for Patients with Non-ST-Elevation Acute Coronary Syndrome Treated with Magmaris and Absorb Bioresorbable Scaffolds in Large-Vessel Lesions. J Pers Med. 2024;14. doi:10.3390/jpm14050540
  6. Galli S, Troiano S, Palloshi A, Rapetto C, Pisano F, et al. Comparison of acute versus stable coronary syndrome in patients treated with the Magmaris scaffold: Two-year results from the Magmaris Multicenter Italian Registry. Cardiovasc Revasc Med. 2023;57:53. doi:10.1016/j.carrev.2023.06.022
  7. Włodarczak A, Rola P, Barycki M, Furtan Ł, Łanocha M, et al. Mid-term safety and efficacy of magnesium bioresorbable vascular scaffolds - magmaris in diabetic population. 2-Years outcome in acute coronary syndrome cohort. Diab Vasc Dis Res. 2023;20:14791641231188705. doi:10.1177/14791641231188705
  8. Gotru SK, Mammadova-Bach E, Sogkas G, Schuhmann MK, Schmitt K, et al. MAGT1 Deficiency Dysregulates Platelet Cation Homeostasis and Accelerates Arterial Thrombosis and Ischemic Stroke in Mice. Arterioscler Thromb Vasc Biol. 2023;43:1494. doi:10.1161/ATVBAHA.122.318115
  9. Haude M, Wlodarczak A, van der Schaaf RJ, Torzewski J, Ferdinande B, et al. A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study. EuroIntervention. 2023;19:e414. doi:10.4244/EIJ-D-23-00326
  10. Wlodarczak A, Montorsi P, Torzewski J, Bennett J, Starmer G, et al. One- and two-year clinical outcomes of treatment with resorbable magnesium scaffolds for coronary artery disease: the prospective, international, multicentre BIOSOLVE-IV registry. EuroIntervention. 2023;19:232. doi:10.4244/EIJ-D-22-01069
  11. Haude M, Wlodarczak A, van der Schaaf RJ, Torzewski J, Ferdinande B, et al. Safety and performance of the third-generation drug-eluting resorbable coronary magnesium scaffold system in the treatment of subjects with de novo coronary artery lesions: 6-month results of the prospective, multicenter BIOMAG-I first-in-human study. EClinicalMedicine. 2023;59:101940. doi:10.1016/j.eclinm.2023.101940
  12. Pompei G, Campo G, Ruggiero R, Maffeo D, Sgura F, et al. Long-term outcomes of patients treated with sirolimus-eluting resorbable magnesium scaffolds: Insights from the SHERPA-MAGIC study. Int J Cardiol. 2023;383:1. doi:10.1016/j.ijcard.2023.04.029
  13. Fedele G, Castiglioni S, Maier JAM, Locatelli L. The Effects of Sirolimus and Magnesium on Primary Human Coronary Endothelial Cells: An In Vitro Study. Int J Mol Sci. 2023;24. doi:10.3390/ijms24032930
  14. Tonai K, Katayama S, Koyama K, Sata N, Tomioka Y, et al. Association between hypomagnesemia and coagulopathy in sepsis: a retrospective observational study. BMC Anesthesiol. 2022;22:359. doi:10.1186/s12871-022-01903-2
  15. Seguchi M, Aytekin A, Lenz T, Nicol P, Alvarez-Covarrubias HA, et al. Challenges of the newer generation of resorbable magnesium scaffolds: Lessons from failure mechanisms of the past generation. J Cardiol. 2023;81:179. doi:10.1016/j.jjcc.2022.09.003
  16. Venkatappa MM, Udagani C, Hanumegowda SM, Pramod SN, Venkataramaiah S, et al. Effect of Biofunctional Green Synthesized MgO-Nanoparticles on Oxidative-Stress-Induced Tissue Damage and Thrombosis. Molecules. 2022;27. doi:10.3390/molecules27165162
image